The Effect of Insulin-Induced Hypoglycaemia on Factor VIII: C Concentrations and Thrombin Activity in Subjects with Type 1 (Insulin-Dependent) Diabetes
Sally H Ibbotson
The Division of Medicine, The General Infirmary, Leeds, UK
,
Andrew Catto
The Division of Medicine, The General Infirmary, Leeds, UK
,
Andrew Davies
The Division of Medicine, The General Infirmary, Leeds, UK
,
Peter J Grant
The Division of Medicine, The General Infirmary, Leeds, UK
The effect of insulin-induced hypoglycaemia on plasma coagulant activity was studied in 11 subjects with well-controlled, uncomplicated type 1 diabetes. Thrombin generation was determined in plasma by a computer ex-vivo assisted chromogenic method and by the activated partial thromboplastin time (APTT). In addition, factor VIII :C, thrombin-antithrombin III (TAT) complex and fibrindpeptide A (FPA) levels were measured. Hypoglycaemia induced a rise in mean (SD) factor VIII: C concentrations from a baseline level of 1.13 (0.32) IU/ml to a peak 15 min after onset of symptoms and they remained increased at 90 min [1.54 (0.57) and 1.5 (0.54) IU/ml, p <;0.001 respectively]. A corresponding reduction in time to generate 50% maximal thrombin activity occurred from a pre-insulin value of 56 (6) s to a minimum reading of 46 (7) s at 15 min (p <;0.001) and remained low at 90 min [48 (6) s, p <;0.001]. APTT shortened from 43.3 (4.8) s to 40.1 (4.6) s at 30 min (p <;0.001) but did not fall below the normal range (37.6-42.7 s) and no significant changes in TAT or FPA levels were noted. Factor VIII: C correlated inversely with time to generate 50% maximal thrombin activity and APTT (r = -0.580, p <;0.001; r = -0.673, p <;0.001, n = 66, respectively). The results show that the rise in plasma factor VIII: C levels induced by hypoglycaemia is accompanied by accelerated rates of generation of thrombin in contact-activated plasma, though concentrations of FPA and TAT remain unchanged, although TAT complexes are not a sensitive marker of in vivo thrombin generation.
References
1
West KM.
Hyperglycaemia as a cause of long term complications. In: >Complications of Diabetes.
Keen H,
Janet J.
eds
Edward Arnold; London: 1982. pp 13-18
4
Lauritzen T,
Frost-Larsen K,
Larsen H-W,
Deckert T.
Steno Study Group, Effects of one year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetics. Lancet 1983; 1: 200-204
7
Dahl-Jprgensen K,
Brinchmann-Hansen O,
Hanssen KF,
Sandvik L,
Aagendes Ø.
Aker diabetes group. Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study Br Med J 1985; 290: 811-815
10
Conall RJ M,
Webber RG,
Frier BM.
Increase in coagulation factor VIII activity in man following acute hypoglycaemia: mediation via an adrenergic mechanism. Br J Haematol 1980; 44: 301-305
11
Lowe GD o,
Middleton SM,
Hay ID,
Beastall GH,
Singar-Avelo O,
Cohen HN,
Thomson JA,
Forbes CD,
Prentice CR M.
Effects of growth hormone. glucose and insulin on the factor VIII complex Thromb Res 1982; 28: 201-211
12
Grant PJ,
Davies JA,
Tate GM,
Boothby M,
Prentice CR M.
Effects of physiological concentrations of vasopressin on haemostatic function in man. Clinical Science 1985; 69: 471-476
13
Grant PJ,
Stickland MH,
Wiles PG,
Davies JA,
Wales JK,
Prentice CR M.
Hormonal control of haemostasis during hypoglycaemia in diabetes mellitus. Thromb Haemost 1987; 57: 341-344
14
Thompson CJ,
Thow J,
Jones IR,
Baylis PH.
Vasopressin secretion during insulin-induced hypoglycaemia: exaggerated response in people with type I diabetes,. Diab Med 1989; 6: 158-163
15
Dalsgaard-Nielsen J,
Madsbad S,
Hilstead J.
Changes in platelet function. blood coagulation and fibrinolysis during insulin-induced hypoglycaemia in juvenile diabetics and normal subjects Thromb Haemost 1982; 47: 254-258
16
Fisher BM,
Quin JD,
Rumley A,
Lennie SE,
Small M,
MacCuish AC,
Lowe GD o.
Effect of acute insulin-induced hypoglyycaemia on haemostasis. fibrinolysis and haemotrheology in insulin-dependent diabetic patients and control subjects Clin Sci 1991; 80: 525-531
17
Hemker HC,
Willems GM,
Beguin S.
A computer assisted method to obtain the prothrombin activation velocity in whole plasma independent of thrombin decay processes. Thromb Haemost 1986; 56: 9-17
19
Thompson JM,
Poller L.
The activated partial thromboplastin time. In: Blood Coagulation and Haemostasis, a practical guide.
Thompson JM.
ed
3rd edition Churchill Livingstone: 1985. pp 301-339
21
Porta M,
Kohner EM,
Molinatti GM.
In vivo studies of endothelial cell function in diabetic microangiopathy. In: Vascular and neurological complications of diabetes mellitus.
Belifore F,
Molinatti GM,
Williamson JR.
(eds)
>Frontiers in Diabetes vol 8; Karger, Basel: 1987. pp 16-28
22
Bern MM,
Cassani NP,
Horton J,
Rand L,
Davis G.
Changes in fibrinolysis and factor VIII coagulant antigen and ristocetin co-factor in diabetes mellitus and arteriosclerosis. Thromb Res 1980; 19: 831-839
25
Porta M,
Townsend C,
Clover GM,
Nanson M,
Alderson AR,
McCraw A,
Kohner EM.
Evidence for functional endothelial cell damage in early diabetic retinopathy. Diabetologia 1981; 20: 597-601
